Altimmune, Inc. Contracts & Agreements

215 Contracts & Agreements
Browse by Contract Category
Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Loan and Security Agreement among Altimmune, Inc., Affiliates, and Hercules Capital, Inc. (May 13, 2025)
Loan Agreements
Altimmune, Inc.
Biotechnology
DC
2025
Description of Altimmune, Inc. Securities Registered Under Section 12 of the Securities Exchange Act of 1934
Equity Distribution Agreements
Altimmune, Inc.
Biotechnology
2025
Altimmune, Inc. Non-Employee Director Compensation Policy (Effective January 1, 2025)
Compensation Agreements
Altimmune, Inc.
Biotechnology
2025
Altimmune, Inc. Consulting Agreement with Catherine Sohn (Effective January 15, 2025)
Consulting Agreements
Altimmune, Inc.
Biotechnology
MD
2025
Employment Agreement between Altimmune, Inc. and Greg Weaver (Chief Financial Officer)
Employment Agreements
Altimmune, Inc.
Biotechnology
MD
2024
Description of Altimmune, Inc. Securities Registered Under Section 12 of the Exchange Act
Equity Distribution Agreements
Altimmune, Inc.
Biotechnology
2024
Altimmune, Inc. Non-Employee Director Compensation Policy (Effective January 1, 2022)
Compensation Agreements
Altimmune, Inc.
Biotechnology
2023
Employment Agreement between Altimmune, Inc. and Raymond Jordt (Chief Business Officer)
Employment Agreements
Altimmune, Inc.
Biotechnology
MD
2023
Employment Agreement between Altimmune, Inc. and Richard I. Eisenstadt (Chief Financial Officer)
Employment Agreements
Altimmune, Inc.
Biotechnology
TX
2021
Amendment No. 6 to Second Restated License Agreement between Janssen Vaccines & Prevention B.V. and Altimmune, Inc.
License Agreements
Altimmune, Inc.
Biotechnology
2021
Statement of Work SOW A-04 between Altimmune Inc. and Lonza Houston Inc. for Engineering and Qualification of Dedicated Manufacturing Suite
Services Agreements
Altimmune, Inc.
Biotechnology
2021
Amendment No. 5 to Second Restated License Agreement between Janssen Vaccines & Prevention B.V. and Altimmune, Inc.
License Agreements
Altimmune, Inc.
Biotechnology
2021
Altimmune, Inc. and Venrock Entities Section 3(a)(9) Exchange Agreement (February 2021)
Exchange Agreements
Altimmune, Inc.
Biotechnology
2021
Amendment No. 4 to Second Restated License Agreement between Janssen Vaccines & Prevention B.V. and Altimmune, Inc.
License Agreements
Altimmune, Inc.
Biotechnology
2020
Altimmune, Inc. Non-Employee Director Compensation Policy (Effective January 1, 2021)
Compensation Agreements
Altimmune, Inc.
Biotechnology
2020
Amendment No. 2 to Second Restated License Agreement between Crucell Holland B.V. and Altimmune, Inc.
License Agreements
Altimmune, Inc.
Biotechnology
2020
Amendment No. 3 to Second Restated License Agreement between Janssen Vaccines & Prevention B.V. and Altimmune, Inc.
License Agreements
Altimmune, Inc.
Biotechnology
2020
Amended and Restated License Agreement between Mederis Diabetes, LLC and Spitfire Pharma, Inc.
License Agreements
Altimmune, Inc.
Biotechnology
CA
2019
Employment Agreement between M. Scott Harris, M.D. and Altimmune, Inc. (Chief Medical Officer)
Employment Agreements
Altimmune, Inc.
Biotechnology
MD
2019
Transition Services Agreement between Altimmune, Inc. and Sybil Tasker (Tropical and Infectious Disease Resources, LLC)
Transition Agreements
Altimmune, Inc.
Biotechnology
MD
2019
Release of Claims Agreement between Altimmune, Inc. and Sybil Tasker (June 17, 2019)
Release Agreements
Altimmune, Inc.
Biotechnology
MD
2019
Employment Agreement between Altimmune, Inc. and William M. Brown (Chief Financial Officer)
Employment Agreements
Altimmune, Inc.
Biotechnology
CO
2019
Amendment to Consulting Agreement between Altimmune, Inc. and Will Brown
Consulting Agreements
Altimmune, Inc.
Biotechnology
2019
Placement Agency Agreement between Altimmune, Inc. and Roth Capital Partners, LLC (March 8, 2019)
Underwriting Agreements
Altimmune, Inc.
Biotechnology
NY
2019
Altimmune, Inc. Warrant to Purchase Common Stock (March 12, 2019)
Warrant Agreements
Altimmune, Inc.
Biotechnology
NY
2019
General Release Agreement between William J. Enright and Altimmune, Inc. (November 30, 2018)
Separation Agreements
Altimmune, Inc.
Biotechnology
MD
2018
Altimmune, Inc. Consulting Agreement with William Enright (November 30, 2018)
Consulting Agreements
Altimmune, Inc.
Biotechnology
MD
2018
Altimmune, Inc. 2018 Inducement Grant Plan
Bonus & Incentive Agreements
Altimmune, Inc.
Biotechnology
DE
2018
Employment Agreement between Dr. Vipin K. Garg and Altimmune, Inc. dated November 16, 2018
Employment Agreements
Altimmune, Inc.
Biotechnology
NC
2018
Consulting Agreement between Altimmune, Inc. and Will Brown for Interim CFO Services
Consulting Agreements
Altimmune, Inc.
Biotechnology
MD
2018
General Release Agreement between Elizabeth A. Czerepak and Altimmune, Inc.
Separation Agreements
Altimmune, Inc.
Biotechnology
MD
2018
Exchange Agreement between Altimmune, Inc. and Holder for Preferred Shares and Warrants
Exchange Agreements
Altimmune, Inc.
Biotechnology
DE
2018
Exchange Agreement among Altimmune, Inc., Holder, and Transferee Holder Dated June 22, 2018
Exchange Agreements
Altimmune, Inc.
Biotechnology
DE
2018
Exchange Agreement between Altimmune, Inc. and Holder (June 22, 2018)
Exchange Agreements
Altimmune, Inc.
Biotechnology
DE
2018
Altimmune, Inc. Incentive Stock Option Agreement with William Enright (2017 Omnibus Incentive Plan)
Bonus & Incentive Agreements
Altimmune, Inc.
Biotechnology
DE
2017
Altimmune, Inc. Incentive Stock Option Agreement with Elizabeth Czerepak (2017)
Bonus & Incentive Agreements
Altimmune, Inc.
Biotechnology
DE
2017
Altimmune, Inc. Incentive Stock Option Agreement with William Enright (2017 Omnibus Incentive Plan)
Bonus & Incentive Agreements
Altimmune, Inc.
Biotechnology
DE
2017
Altimmune, Inc. Incentive Stock Option Agreement with Elizabeth Czerepak (2017 Omnibus Incentive Plan)
Bonus & Incentive Agreements
Altimmune, Inc.
Biotechnology
DE
2017
Altimmune, Inc. Incentive Stock Option Agreement with Elizabeth Czerepak (2017)
Bonus & Incentive Agreements
Altimmune, Inc.
Biotechnology
DE
2017
Amended and Restated Exclusive License Agreement between The UAB Research Foundation and Vaxin Inc.
License Agreements
Altimmune, Inc.
Biotechnology
AL
2017
First Amendment to Amended and Restated Exclusive License Agreement between Altimmune, Inc. and The UAB Research Foundation
License Agreements
Altimmune, Inc.
Biotechnology
2017
Second Restated License Agreement between Crucell Holland B.V. and Vaxin Inc.
License Agreements
Altimmune, Inc.
Biotechnology
2017
Amendment No. 1 to Second Restated License Agreement between Crucell Holland B.V. and Altimmune Inc.
License Agreements
Altimmune, Inc.
Biotechnology
2017
Amended and Restated Employment Agreement between William J. Enright and Altimmune Inc.
Employment Agreements
Altimmune, Inc.
Biotechnology
MD
2017
First Amendment to Amended and Restated Employment Agreement between Altimmune, Inc. and William J. Enright
Employment Agreements
Altimmune, Inc.
Biotechnology
2017
Employment Agreement between Altimmune, Inc. and Elizabeth Czerepak (Chief Financial Officer)
Employment Agreements
Altimmune, Inc.
Biotechnology
MD
2017
First Amendment to Employment Agreement between Altimmune, Inc. and Elizabeth Czerepak
Employment Agreements
Altimmune, Inc.
Biotechnology
2017
Employment Agreement between M. Scot Roberts and Altimmune, Inc. (December 7, 2015)
Employment Agreements
Altimmune, Inc.
Biotechnology
MD
2017
Employment Agreement between Sybil Tasker and Altimmune, Inc. dated April 4, 2016
Employment Agreements
Altimmune, Inc.
Biotechnology
WA
2017
Altimmune, Inc. Convertible Promissory Note Purchase Agreement with Purchasers (January 18, 2017)
Note Agreements
Altimmune, Inc.
Biotechnology
DE
2017
Altimmune, Inc. 2017 Omnibus Incentive Plan
Bonus & Incentive Agreements
Altimmune, Inc.
Biotechnology
DE
2017
Altimmune, Inc. Incentive Stock Option Agreement under 2017 Omnibus Incentive Plan
Bonus & Incentive Agreements
Altimmune, Inc.
Biotechnology
DE
2017
Agreement and Plan of Merger and Reorganization among PharmAthene, Inc., Altimmune, Inc., and Affiliates (2017)
Merger Agreements
Altimmune, Inc.
Biotechnology
CO
2017
PharmAthene, Inc. Retention and Severance Bonus Agreement with Philip MacNeill
Retention Agreements
Altimmune, Inc.
Biotechnology
2017
Employment Agreement between PharmAthene, Inc. and John M. Gill
Employment Agreements
Altimmune, Inc.
Biotechnology
MD
2016
Separation Agreement and General Release and Waiver between PharmAthene, Inc. and Francesca Cook
Separation Agreements
Altimmune, Inc.
Biotechnology
MD
2015
Separation Agreement and General Release and Waiver between PharmAthene, Inc. and Eric Richman
Separation Agreements
Altimmune, Inc.
Biotechnology
MD
2015
Separation Agreement and General Release and Waiver between PharmAthene, Inc. and Wayne Morges, Ph.D.
Separation Agreements
Altimmune, Inc.
Biotechnology
MD
2015
Separation Agreement and General Release and Waiver between PharmAthene, Inc. and Linda Chang
Separation Agreements
Altimmune, Inc.
Biotechnology
MD
2015
Contract for Development of Vaccine Formulations Effective Against NIAID Priority Pathogens between PharmAthene, Inc. and NIH/NIAID
Services Agreements
Altimmune, Inc.
Biotechnology
2014
Amendment to Employment Agreement between PharmAthene, Inc. and Eric Richman (July 31, 2013)
Employment Agreements
Altimmune, Inc.
Biotechnology
2013
Amendment to Employment Agreement between PharmAthene, Inc. and Linda Chang (July 31, 2013)
Employment Agreements
Altimmune, Inc.
Biotechnology
2013
Employment Agreement between PharmAthene, Inc. and Francesca Cook dated April 18, 2008
Employment Agreements
Altimmune, Inc.
Biotechnology
MD
2013
Employment Agreement between PharmAthene, Inc. and Jordan Karp dated June 30, 2008
Employment Agreements
Altimmune, Inc.
Biotechnology
MD
2012
Employment Agreement between PharmAthene, Inc. and Linda Chang (Senior Vice President, CFO)
Employment Agreements
Altimmune, Inc.
Biotechnology
MD
2012
PharmAthene, Inc. Placement Agency Agreement with Leerink Swann LLC and Noble Financial Capital Markets (June 2011)
Underwriting Agreements
Altimmune, Inc.
Biotechnology
MA
2011
Unit Subscription Agreement between PharmAthene, Inc. and Investor (June 10, 2011)
Subscription Agreements
Altimmune, Inc.
Biotechnology
NY
2011
Employment Agreement between PharmAthene, Inc. and Charles A. Reinhart III (August 14, 2009)
Employment Agreements
Altimmune, Inc.
Biotechnology
MD
2011
Employment Agreement between PharmAthene, Inc. and Thomas R. Fuerst
Employment Agreements
Altimmune, Inc.
Biotechnology
MD
2011
Employment Agreement between PharmAthene, Inc. and Eric Richman dated December 23, 2010
Employment Agreements
Altimmune, Inc.
Biotechnology
MD
2010
Amendment to Employment Agreement between PharmAthene, Inc. and Eric Richman dated May 18, 2010
Employment Agreements
Altimmune, Inc.
Biotechnology
2010
Employment Agreement between PharmAthene, Inc. and Eric Richman dated April 18, 2008
Employment Agreements
Altimmune, Inc.
Biotechnology
MD
2010
Employment Agreement between PharmAthene, Inc. and Wayne Morges, Ph.D.
Employment Agreements
Altimmune, Inc.
Biotechnology
MD
2010
PharmAthene, Inc. Senior Unsecured Convertible Note Issued July 28, 2009
Note Agreements
Altimmune, Inc.
Biotechnology
NY
2009
PharmAthene, Inc. Note and Warrant Purchase Agreement with Investors (July 24, 2009)
Note Agreements
Altimmune, Inc.
Biotechnology
DE
2009
Registration Rights Agreement between PharmAthene, Inc. and Investors (July 28, 2009)
Registration Rights Agreements
Altimmune, Inc.
Biotechnology
DE
2009
First Amendment to Employment Agreement between PharmAthene, Inc. and David P. Wright
Employment Agreements
Altimmune, Inc.
Biotechnology
2009
Amended and Restated Manufacturing and Marketing License Agreement between UK Secretary of State for Defence (Dstl) and PharmAthene UK Ltd. for Recombinant Vaccine
License Agreements
Altimmune, Inc.
Biotechnology
2009
Amended and Restated License Agreement between The Secretary of State for Defence (Dstl) and PharmAthene UK Ltd. for Recombinant Vaccine
License Agreements
Altimmune, Inc.
Biotechnology
2009
Employment Agreement between PharmAthene, Inc. and Executive
Employment Agreements
Altimmune, Inc.
Biotechnology
MD
2008
PharmAthene, Inc. Confidentiality and Non-Solicitation Agreement with Employee or Consultant
Confidentiality Agreements
Altimmune, Inc.
Biotechnology
2008
Master Services Agreement between PharmAthene UK Limited and Avecia Biologics Limited (April 2, 2008)
Services Agreements
Altimmune, Inc.
Biotechnology
2008
Transitional Services Agreement between Avecia Biologics Limited and PharmAthene UK Limited (April 2, 2008)
Services Agreements
Altimmune, Inc.
Biotechnology
2008
Amendment Agreement to Sale and Purchase Agreement for Avecia Vaccines Business between Avecia Investments Limited, PharmAthene, Inc., and Others (April 2, 2008)
Modification Agreements
Altimmune, Inc.
Biotechnology
2008
Stock Escrow Agreement among Healthcare Acquisition Corp., MPM BioVentures III-QP, LP, John Pappajohn, and Continental Stock Transfer & Trust Company (August 3, 2007)
Escrow Agreements
Altimmune, Inc.
Biotechnology
DE
2008
Employment Agreement between PharmAthene, Inc. and Christopher C. Camut (Vice President & CFO)
Employment Agreements
Altimmune, Inc.
Biotechnology
MD
2007
Employment Agreement between PharmAthene, Inc. and Francesca Marie Cook
Employment Agreements
Altimmune, Inc.
Biotechnology
MD
2007
Employment Agreement between PharmAthene, Inc. and Eric Ian Richman
Employment Agreements
Altimmune, Inc.
Biotechnology
MD
2007
Employment Agreement between PharmAthene, Inc. and Valerie Dean Riddle
Employment Agreements
Altimmune, Inc.
Biotechnology
MD
2007
Employment Agreement between PharmAthene, Inc. and Wayne Morges (Vice President Regulatory Affairs & Quality)
Employment Agreements
Altimmune, Inc.
Biotechnology
MD
2007
Loan and Security Agreement between Silicon Valley Bank, Oxford Finance Corporation, and PharmAthene, Inc. dated March 30, 2007
Loan Agreements
Altimmune, Inc.
Biotechnology
MA
2007
U.S. Army Space & Missile Defense Command and PharmAthene, Inc. Development and Licensure Contract for Bioscavenger Increment II
Services Agreements
Altimmune, Inc.
Biotechnology
2007
Cooperative Research and Development Agreement between PharmAthene, Inc. and U.S. Army Medical Research Institute of Infectious Diseases
Collaboration Agreements
Altimmune, Inc.
Biotechnology
2007
NIH Cooperative Research Grant Award Agreement between National Institutes of Health and PharmAthene, Inc.
Funding Agreements
Altimmune, Inc.
Biotechnology
2007
Collaboration Agreement between PharmAthene, Inc. and Medarex, Inc. for Anthrax Antibody Development
Collaboration Agreements
Altimmune, Inc.
Biotechnology
DE
2007
Research and License Agreement between Nektar Therapeutics AL and PharmAthene, Inc. (August 8, 2006)
License Agreements
Altimmune, Inc.
Biotechnology
DE
2007
Services Agreement between PharmAthene, Inc. and GTC Biotherapeutics, Inc. dated March 2, 2007
Services Agreements
Altimmune, Inc.
Biotechnology
DE
2007
License Agreement between GTC Biotherapeutics, Inc. and PharmAthene, Inc. (March 12, 2007)
License Agreements
Altimmune, Inc.
Biotechnology
DE
2007
Biopharmaceutical Development and Manufacturing Services Agreement between PharmAthene, Inc. and Laureate Pharma, Inc.
Services Agreements
Altimmune, Inc.
Biotechnology
DE
2007
First Amendment to Office Lease between Park Place Trust and PharmAthene, Inc.
Lease Agreements
Altimmune, Inc.
Biotechnology
2007
Healthcare Acquisition Corp. 2007 Long-Term Incentive Compensation Plan
Bonus & Incentive Agreements
Altimmune, Inc.
Biotechnology
DE
2007
Employment Agreement between David P. Wright and Healthcare Acquisition Corp.
Employment Agreements
Altimmune, Inc.
Biotechnology
2007
Amendment to Unit Purchase Option between Healthcare Acquisition Corp. and Maxim Partners, LLC
Modification Agreements
Altimmune, Inc.
Biotechnology
2007
Warrant Clarification Agreement between Healthcare Acquisition Corp. and Continental Stock Transfer & Trust Company
Warrant Agreements
Altimmune, Inc.
Biotechnology
2007
Advisory Agreement between Healthcare Acquisition Corp. and Maxim Group LLC (January 8, 2007)
Advisory Agreements
Altimmune, Inc.
Biotechnology
2007
Agreement and Plan of Merger among Healthcare Acquisition Corp., PAI Acquisition Corp., and PharmAthene, Inc. dated January 19, 2007
Merger Agreements
Altimmune, Inc.
Biotechnology
DE
2007
Note Exchange Agreement between PharmAthene, Inc. and Note Holders (2007)
Exchange Agreements
Altimmune, Inc.
Biotechnology
2007
PharmAthene, Inc. Senior Unsecured Convertible Note Issued to [Holder]
Note Agreements
Altimmune, Inc.
Biotechnology
NY
2007
Registration Rights Agreement between Healthcare Acquisition Corp. and Investors (PharmAthene Merger)
Registration Rights Agreements
Altimmune, Inc.
Biotechnology
2007
Lock-Up Agreement Related to Healthcare Acquisition Corp./PharmAthene, Inc. Merger
Altimmune, Inc.
Biotechnology
2007
Amendment No. 1 to Investment Management Trust Agreement between Healthcare Acquisition Corp. and Continental Stock Transfer & Trust Company
Trust Agreements
Altimmune, Inc.
Biotechnology
2005
Promissory Note between Healthcare Acquisition Corp. and John Pappajohn dated July 26, 2005
Note Agreements
Altimmune, Inc.
Biotechnology
2005
Promissory Note between Healthcare Acquisition Corp. and Derace L. Schaffer, M.D. dated July 26, 2005
Note Agreements
Altimmune, Inc.
Biotechnology
2005
Promissory Note between Healthcare Acquisition Corp. and Matthew P. Kinley dated July 26, 2005
Note Agreements
Altimmune, Inc.
Biotechnology
2005
Underwriting Agreement between Healthcare Acquisition Corp. and Maxim Group LLC (2005)
Underwriting Agreements
Altimmune, Inc.
Biotechnology
NY
2005
Selected Dealer Agreement between Healthcare Acquisition Corporation, Maxim Group LLC, and Selected Dealer for Public Offering of Units
Underwriting Agreements
Altimmune, Inc.
Biotechnology
2005
Warrant Agreement between Healthcare Acquisition Corp. and Continental Stock Transfer & Trust Company
Warrant Agreements
Altimmune, Inc.
Biotechnology
NY
2005
Restated Letter Agreement Among Healthcare Acquisition Corp., Maxim Group LLC, and Edward Berger Regarding IPO and Business Combination
Underwriting Agreements
Altimmune, Inc.
Biotechnology
2005
Letter Agreement Among Healthcare Acquisition Corp., Maxim Group LLC, and Schellhammer Regarding IPO and Business Combination
Altimmune, Inc.
Biotechnology
2005
Investment Management Trust Agreement between Healthcare Acquisition Corp. and Continental Stock Transfer & Trust Company
Trust Agreements
Altimmune, Inc.
Biotechnology
2005
Stock Escrow Agreement among Healthcare Acquisition Corp., Initial Stockholders, and Continental Stock Transfer & Trust Company
Escrow Agreements
Altimmune, Inc.
Biotechnology
NY
2005
Unit Purchase Option Agreement between Healthcare Acquisition Corp. and Maxim Partners LLC
Warrant Agreements
Altimmune, Inc.
Biotechnology
NY
2005
Stock Escrow Agreement among Healthcare Acquisition Corp., Initial Stockholders, and Continental Stock Transfer & Trust Company
Escrow Agreements
Altimmune, Inc.
Biotechnology
IA
2005
Healthcare Acquisition Corp. Unit Certificate Representing Common Stock and Warrants
Stock Agreements
Altimmune, Inc.
Biotechnology
2005
Common Stock Certificate for Healthcare Acquisition Corp.
Stock Agreements
Altimmune, Inc.
Biotechnology
2005
Healthcare Acquisition Corp. Warrant Certificate for Purchase of Common Stock
Warrant Agreements
Altimmune, Inc.
Biotechnology
2005
Registration Rights Agreement between Healthcare Acquisition Corp. and Investors (2005)
Registration Rights Agreements
Altimmune, Inc.
Biotechnology
DE
2005
Office and Secretarial Services Agreement between Healthcare Acquisition Corp. and Equity Dynamics Inc. (April 28, 2005)
Services Agreements
Altimmune, Inc.
Biotechnology
2005
Office and Secretarial Services Agreement between Healthcare Acquisition Corp. and The Lan Group (April 28, 2005)
Services Agreements
Altimmune, Inc.
Biotechnology
2005
Promissory Note between Healthcare Acquisition Corp. and John Pappajohn dated April 28, 2005
Note Agreements
Altimmune, Inc.
Biotechnology
2005
Promissory Note between Healthcare Acquisition Corp. and Derace L. Schaffer, M.D. ($70,000, April 28, 2005)
Note Agreements
Altimmune, Inc.
Biotechnology
2005
Promissory Note Between Healthcare Acquisition Corp. and Matthew P. Kinley Dated April 28, 2005
Note Agreements
Altimmune, Inc.
Biotechnology
2005
Description of Altimmune, Inc. Securities Registered Under Section 12 of the Exchange Act
Equity Distribution Agreements
Altimmune, Inc.
Biotechnology
2023
Description of Altimmune, Inc. Securities Registered Under Section 12 of the Exchange Act
Equity Distribution Agreements
Altimmune, Inc.
Biotechnology
2022
Amendment No. P00008 to Contract HHSO100201600008C Between Altimmune, Inc. and U.S. Department of Health & Human Services
Modification Agreements
Altimmune, Inc.
Biotechnology
2021
Amendment No. P00007 to Contract HHSO100201600008C Between Altimmune, Inc. and HHS/ASPR/BARDA
Modification Agreements
Altimmune, Inc.
Biotechnology
2021
Description of Altimmune, Inc. Securities Registered Under Section 12 of the Exchange Act
Equity Distribution Agreements
Altimmune, Inc.
Biotechnology
2021
Amendment No. P00006 to Contract HHSO100201600008C between U.S. Department of Health & Human Services and Altimmune, Inc.
Modification Agreements
Altimmune, Inc.
Biotechnology
2021
Altimmune, Inc. Equity Distribution Agreement with Piper Sandler & Co., Evercore Group L.L.C., and B. Riley Securities, Inc.
Equity Distribution Agreements
Altimmune, Inc.
Biotechnology
NY
2021
Altimmune, Inc. Form of Pre-Funded Warrant to Purchase Common Stock (February 25, 2021)
Warrant Agreements
Altimmune, Inc.
Biotechnology
NY
2021
Altimmune, Inc. Underwriting Agreement with Jefferies LLC, Evercore Group L.L.C., and Piper Sandler & Co. (July 13, 2020)
Underwriting Agreements
Altimmune, Inc.
Biotechnology
NY
2020
Altimmune, Inc. Form of Pre-Funded Warrant to Purchase Common Stock (July 2020)
Warrant Agreements
Altimmune, Inc.
Biotechnology
NY
2020
Description of Altimmune, Inc. Securities Registered Under Section 12 of the Exchange Act
Equity Distribution Agreements
Altimmune, Inc.
Biotechnology
2020
Altimmune, Inc. $50,000,000 Equity Distribution Agreement with JMP Securities LLC (March 27, 2020)
Equity Distribution Agreements
Altimmune, Inc.
Biotechnology
DE
2020
Amendment No. P00005 to Contract HHSO100201600008C Between Altimmune, Inc. and U.S. Department of Health & Human Services
Modification Agreements
Altimmune, Inc.
Biotechnology
2019
Lock-Up Agreement between Altimmune, Inc. and Spitfire Pharma, Inc. Stockholders (July 2019)
Altimmune, Inc.
Biotechnology
2019
Agreement and Plan of Merger and Reorganization among Altimmune, Inc., Springfield Merger Subs, and Spitfire Pharma, Inc.
Merger Agreements
Altimmune, Inc.
Biotechnology
DE
2019
Altimmune, Inc. Pre-Funded Warrant to Purchase Common Stock (March 12, 2019)
Warrant Agreements
Altimmune, Inc.
Biotechnology
NY
2019
Securities Purchase Agreement between Altimmune, Inc. and Purchasers dated March 8, 2019
Purchase Agreements
Altimmune, Inc.
Biotechnology
NY
2019
Altimmune, Inc. Nonqualified Stock Option Agreement under 2018 Inducement Grant Plan
Warrant Agreements
Altimmune, Inc.
Biotechnology
DE
2018
Altimmune, Inc. Restricted Stock Agreement under 2018 Inducement Grant Plan
Equity Distribution Agreements
Altimmune, Inc.
Biotechnology
DE
2018
Altimmune, Inc. Restricted Stock Agreement under 2017 Omnibus Incentive Plan
Equity Distribution Agreements
Altimmune, Inc.
Biotechnology
DE
2018
Placement Agency Agreement between Altimmune, Inc. and Roth Capital Partners, LLC (October 8, 2018)
Underwriting Agreements
Altimmune, Inc.
Biotechnology
NY
2018
Altimmune, Inc. Pre-Funded Warrant to Purchase Common Stock (Form of Warrant)
Warrant Agreements
Altimmune, Inc.
Biotechnology
NY
2018
Altimmune, Inc. Warrant to Purchase Common Stock (Form of Warrant)
Warrant Agreements
Altimmune, Inc.
Biotechnology
NY
2018
Securities Purchase Agreement between Altimmune, Inc. and Purchasers (October 8, 2018)
Purchase Agreements
Altimmune, Inc.
Biotechnology
NY
2018
Altimmune, Inc. Underwriting Agreement with Roth Capital Partners, LLC (September 2018)
Underwriting Agreements
Altimmune, Inc.
Biotechnology
NY
2018
Altimmune, Inc. Pre-Funded Warrant to Purchase Common Stock (Form of Warrant)
Warrant Agreements
Altimmune, Inc.
Biotechnology
NY
2018
Altimmune, Inc. Warrant to Purchase Common Stock Agreement
Warrant Agreements
Altimmune, Inc.
Biotechnology
NY
2018
Altimmune, Inc. Underwriter Warrant to Purchase Common Stock (Roth Capital Partners, LLC)
Warrant Agreements
Altimmune, Inc.
Biotechnology
NY
2018
Amendment No. 0004 to Contract HHSO100201600008C Between U.S. Department of Health & Human Services and Altimmune, Inc.
Modification Agreements
Altimmune, Inc.
Biotechnology
2018
Placement Agency Agreement between Altimmune, Inc. and Roth Capital Partners, LLC (September 24, 2018)
Underwriting Agreements
Altimmune, Inc.
Biotechnology
NY
2018
Securities Purchase Agreement between Altimmune, Inc. and Purchasers (September 24, 2018)
Purchase Agreements
Altimmune, Inc.
Biotechnology
NY
2018
Altimmune, Inc. Preferred Stock Placement Agency Agreement with Piper Jaffray & Co. (August 16, 2017)
Underwriting Agreements
Altimmune, Inc.
Biotechnology
NY
2017
Securities Purchase Agreement between Altimmune, Inc. and Investors (August 16, 2017)
Purchase Agreements
Altimmune, Inc.
Biotechnology
NY
2017
Altimmune, Inc. Warrant to Purchase Common Stock (Form of Warrant)
Warrant Agreements
Altimmune, Inc.
Biotechnology
NY
2017
Research and Development Agreement for Ad5-Vectored Anthrax Vaccine Candidate Between Contractor and U.S. Government
Development Agreements
Altimmune, Inc.
Biotechnology
2017
Amendment No. 0001 to Contract HHSO100201600008C Between ASPR-BARDA and Altimmune, Inc.
Modification Agreements
Altimmune, Inc.
Biotechnology
2017
Indemnification Agreement between Altimmune, Inc. and Director/Officer
Indemnification Agreements
Altimmune, Inc.
Biotechnology
DE
2017
Altimmune, Inc. Nonqualified Stock Option Agreement under 2017 Omnibus Incentive Plan
Warrant Agreements
Altimmune, Inc.
Biotechnology
DE
2017
Amendment No. 1 to Agreement and Plan of Merger among PharmAthene, Inc., Altimmune, Inc., and Others
Merger Agreements
Altimmune, Inc.
Biotechnology
DE
2017
Parent Voting Agreement between Altimmune, Inc. and PharmAthene, Inc. Stockholders (January 18, 2017)
Voting Agreements
Altimmune, Inc.
Biotechnology
DE
2017
PharmAthene Lock-Up Agreement with Stockholder Regarding Merger with Altimmune, Inc.
Altimmune, Inc.
Biotechnology
DE
2017
Lock-Up Agreement between PharmAthene, Inc. and Altimmune, Inc. Stockholder
Altimmune, Inc.
Biotechnology
DE
2017
Section 382 Rights Agreement between PharmAthene, Inc. and Continental Stock Transfer & Trust Company
Altimmune, Inc.
Biotechnology
DE
2015
Termination Agreement among PharmAthene, Inc., Theraclone Sciences, Inc., and Taurus Merger Sub, Inc.
Termination Agreements
Altimmune, Inc.
Biotechnology
2013
Agreement and Plan of Merger among PharmAthene, Inc., Taurus Merger Sub, Inc., Theraclone Sciences, Inc., and Securityholders’ Representative (July 31, 2013)
Merger Agreements
Altimmune, Inc.
Biotechnology
DE
2013
PharmAthene, Inc. Voting and Lock-Up Agreement with Theraclone Sciences, Inc. Stockholders
Voting Agreements
Altimmune, Inc.
Biotechnology
DE
2013
Theraclone Voting and Lock-Up Agreement between PharmAthene, Inc. and Theraclone Stockholders
Voting Agreements
Altimmune, Inc.
Biotechnology
DE
2013
Board Composition Agreement among PharmAthene, Inc. and Certain Stockholders (2013)
Voting Agreements
Altimmune, Inc.
Biotechnology
DE
2013
Post-Closing Lock-Up Agreement between PharmAthene, Inc. and Stockholder (Merger Consideration Shares)
Altimmune, Inc.
Biotechnology
2013
Controlled Equity Offering Sales Agreement between PharmAthene, Inc. and Cantor Fitzgerald & Co. (March 25, 2013)
Equity Distribution Agreements
Altimmune, Inc.
Biotechnology
NY
2013
Loan and Security Agreement among General Electric Capital Corporation, Lenders, and PharmAthene, Inc. dated March 30, 2012
Loan Agreements
Altimmune, Inc.
Biotechnology
NY
2012
Warrant Agreement between PharmAthene, Inc. and GE Capital Equity Investments, Inc. dated March 30, 2012
Warrant Agreements
Altimmune, Inc.
Biotechnology
NY
2012
Offer to Purchase Agreement between PharmAthene Canada, Inc. and Ferme Pillar Hill ENR for Quebec and Ontario Properties
Purchase Agreements
Altimmune, Inc.
Biotechnology
2012
PharmAthene, Inc. Warrant to Purchase Common Stock (June 15, 2011)
Warrant Agreements
Altimmune, Inc.
Biotechnology
NY
2011
Pharmathene, Inc. Restricted Stock Agreement under 2007 Long-Term Incentive Compensation Plan
Equity Distribution Agreements
Altimmune, Inc.
Biotechnology
DE
2011
PharmAthene, Inc. 2007 Long-Term Incentive Plan Nonqualified Stock Option Grant Agreement
Bonus & Incentive Agreements
Altimmune, Inc.
Biotechnology
DE
2011
PharmAthene, Inc. Nonqualified Stock Option Grant Agreement for Non-Employee Directors under 2007 Long-Term Incentive Plan
Bonus & Incentive Agreements
Altimmune, Inc.
Biotechnology
DE
2011
PharmAthene, Inc. and Roth Capital Partners, LLC Underwriting Agreement for 4,300,000 Shares of Common Stock
Underwriting Agreements
Altimmune, Inc.
Biotechnology
NY
2010
Early Conversion Agreement between Pharmathene, Inc. and Note Holders (October 2010)
Modification Agreements
Altimmune, Inc.
Biotechnology
DE
2010
Placement Agent Agreement between PharmAthene, Inc. and Roth Capital Partners, LLC for Public Offering of Securities
Underwriting Agreements
Altimmune, Inc.
Biotechnology
NY
2010
Securities Purchase Agreement between PharmAthene, Inc. and Purchaser (July 20, 2010)
Purchase Agreements
Altimmune, Inc.
Biotechnology
NY
2010
Common Stock Purchase Warrant Agreement between PharmAthene, Inc. and Holder (2010)
Warrant Agreements
Altimmune, Inc.
Biotechnology
2010
Placement Agent Agreement between PharmAthene, Inc. and Roth Capital Partners, LLC (April 7, 2010)
Underwriting Agreements
Altimmune, Inc.
Biotechnology
NY
2010
Securities Purchase Agreement between PharmAthene, Inc. and Purchaser (April 7, 2010)
Purchase Agreements
Altimmune, Inc.
Biotechnology
NY
2010
Common Stock Purchase Warrant Agreement between PharmAthene, Inc. and Holder (April 2010)
Warrant Agreements
Altimmune, Inc.
Biotechnology
2010
Variation and Settlement Agreement among PharmAthene, Inc., Avecia Entities, and Affiliates
Settlement Agreements
Altimmune, Inc.
Biotechnology
2009
PharmAthene, Inc. Warrant to Purchase Common Stock Agreement (No. EX-4.10)
Warrant Agreements
Altimmune, Inc.
Biotechnology
DE
2009
Consent, Assumption, and Second Loan Modification Agreement among Silicon Valley Bank, Oxford Finance Corporation, and PharmAthene, Inc.
Modification Agreements
Altimmune, Inc.
Biotechnology
2009
Placement Agency Agreement between PharmAthene, Inc. and Rodman & Renshaw, LLC (March 23, 2009)
Underwriting Agreements
Altimmune, Inc.
Biotechnology
NY
2009
Placement Agent Engagement Agreement between PharmAthene, Inc. and Caris & Co. (March 23, 2009)
Financing Agreements
Altimmune, Inc.
Biotechnology
NY
2009
Securities Purchase Agreement between Pharmathene, Inc. and Purchasers dated March 23, 2009
Purchase Agreements
Altimmune, Inc.
Biotechnology
NY
2009
Common Stock Purchase Warrant Agreement between Pharmathene, Inc. and Holder (2009)
Warrant Agreements
Altimmune, Inc.
Biotechnology
2009
Indemnification Agreement between PharmAthene, Inc. and Indemnitee
Indemnification Agreements
Altimmune, Inc.
Biotechnology
DE
2009
Amendment No. 1 to Underwriting Agreement between Healthcare Acquisition Corp. and Maxim Group LLC
Underwriting Agreements
Altimmune, Inc.
Biotechnology
2006
Healthcare Acquisition Corp. Underwriting Agreement with Maxim Group LLC and Underwriters
Underwriting Agreements
Altimmune, Inc.
Biotechnology
NY
2005
Warrant Agreement between Healthcare Acquisition Corp. and Continental Stock Transfer & Trust Company (2005)
Warrant Agreements
Altimmune, Inc.
Biotechnology
NY
2005
Insider Letter Agreement between Healthcare Acquisition Corp. and Maxim Group LLC (May 6, 2005)
Altimmune, Inc.
Biotechnology
2005
Insider Letter Agreement between Healthcare Acquisition Corp. and Maxim Group LLC (May 6, 2005)
Investor Rights Agreements
Altimmune, Inc.
Biotechnology
2005
Insider Letter Agreement between Healthcare Acquisition Corp. and Maxim Group LLC Regarding IPO and Business Combination
Investor Rights Agreements
Altimmune, Inc.
Biotechnology
2005
Insider Letter Agreement between Healthcare Acquisition Corp. and Edward B. Berger regarding IPO and Business Combination
Investor Rights Agreements
Altimmune, Inc.
Biotechnology
2005
Investment Management Trust Agreement between Healthcare Acquisition Corp. and Continental Stock Transfer & Trust Company
Trust Agreements
Altimmune, Inc.
Biotechnology
2005
Unit Purchase Option Agreement between Healthcare Acquisition Corp. and Maxim Partners LLC
Warrant Agreements
Altimmune, Inc.
Biotechnology
NY
2005
Warrant Purchase Agreement between Maxim Group LLC and Investor for Healthcare Acquisition Corp.
Warrant Agreements
Altimmune, Inc.
Biotechnology
2005